|
Status |
Public on Jul 31, 2012 |
Title |
HeLa_treated_with_siRNA_against_HCFC1_rep1 |
Sample type |
RNA |
|
|
Source name |
adherent HeLa cells
|
Organism |
Homo sapiens |
Characteristics |
treatment: HCFC1 cell line: HeLa
|
Treatment protocol |
Cells were treated with siRNA against HCF-1 or luciferase, as previously described {Julien, 2003 #4}, twice 12h apart using oligofectamine (Invtrogen).
|
Growth protocol |
Adherent HeLa were grown in Dulbecco’s modified Eagles’s medium (DMEM) with 10% of fetal bovine serum.
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA samples were collected after 48h following the first transfection using Qiagen columns.
|
Label |
biotin
|
Label protocol |
RNA samples were then labeled using the MessageAmp II-Biotin Enhanced kit (Ambion 1791)
|
|
|
Hybridization protocol |
RNA samples were hybridized to GeneChip Human Genome U133 Plus 2.0 Array.
|
Scan protocol |
The chips were scanned as described in the Affymetrix protocol and the .CEL files were generated.
|
Description |
HeLa, cycling
|
Data processing |
3 biological replicates were used for each condition. The intensities of each probeset were normalized and summarized using the Robust Multi-array Analysis algorithm (RMA, {Irizarry, 2003 #114}) and differential expression was assessed using the LIMMA package {Smyth, 2004 #115}.
|
|
|
Submission date |
Aug 16, 2011 |
Last update date |
Jul 31, 2012 |
Contact name |
Nicolo Riggi |
Organization name |
CHUV
|
Department |
Département de Pathologie Expérimentale
|
Lab |
Institut universitaire de pathologie
|
Street address |
Bugnon 25
|
City |
Lausanne |
State/province |
VD |
ZIP/Postal code |
1011 |
Country |
Switzerland |
|
|
Platform ID |
GPL570 |
Series (2) |
GSE31412 |
Expression changes in HeLa cells treated with siRNA against HCFC1 or control luciferase |
GSE31419 |
The epigenetic cell-cycle regulator HCF-1 is recruited to active CpG island-containing promoters together with the ZNF143, THAP11(Ronin), YY-1 and GABP transcription factors. |
|